Hamisch, Christina A., Minartz, Jana, Blau, Tobias, Hafkemeyer, Vanessa, Ruess, Daniel, Hellerbach, Alexandra, Grau, Stefan J. and Ruge, Maximilian I. (2019). Frame-based stereotactic biopsy of deep-seated and midline structures in 511 procedures: feasibility, risk profile, and diagnostic yield. Acta Neurochir., 161 (10). S. 2065 - 2072. WIEN: SPRINGER WIEN. ISSN 0942-0940

Full text not available from this repository.

Abstract

Objectives We evaluated the feasibility, safety, and diagnostic yield of frame-based stereotactic biopsies (SB) in lesions located in deep-seated and midline structures of the brain to analyze these parameters in comparison to other brain areas. Patients and methods In a retrospective, tertiary care single-center analysis, we identified all patients who received SB for lesions localized in deep-seated and midline structures (corpus callosum, basal ganglia, pineal region, sella, thalamus, and brainstem) between January 1996 and June 2015. Study participants were between 1 and 82 years. We evaluated the feasibility, procedural complications (mortality, transient and permanent morbidity), and diagnostic yield. We further performed a risk analysis of factors influencing the latter parameters. Chi-square test, Student t test, and Mann-Whitney rank-sum test were used for statistical analysis. Results Four hundred eighty-nine patients receiving 511 SB procedures (median age 48.5 years, range 1-82; median Karnofsky Performance Score 80%, range 50-100%, 43.8% female/56.2% male) were identified. Lesions were localized in the corpus callosum (29.5%), basal ganglia (17.0%), pineal region (11.5%), sella (7.8%), thalamus (4.3%), brainstem (28.8%), and others (1.1%). Procedure-related mortality was 0%, and permanent morbidity was 0.4%. Transient morbidity was 9.6%. Histological diagnosis was possible in 99.2% (low-grade gliomas 16.2%, high-grade gliomas 40.3%, other tumors in 27.8%, no neoplastic lesions 14.5%, no definitive histological diagnosis 0.8%). Only the pons location correlated significantly with transient morbidity (p < 0.001). Conclusion In experienced centers, frame-based stereotactic biopsy is a safe diagnostic tool with a high diagnostic yield also for deep-seated and midline lesions.

Item Type: Journal Article
Creators:
CreatorsEmailORCIDORCID Put Code
Hamisch, Christina A.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Minartz, JanaUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Blau, TobiasUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Hafkemeyer, VanessaUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Ruess, DanielUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Hellerbach, AlexandraUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Grau, Stefan J.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Ruge, Maximilian I.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
URN: urn:nbn:de:hbz:38-133185
DOI: 10.1007/s00701-019-04020-1
Journal or Publication Title: Acta Neurochir.
Volume: 161
Number: 10
Page Range: S. 2065 - 2072
Date: 2019
Publisher: SPRINGER WIEN
Place of Publication: WIEN
ISSN: 0942-0940
Language: English
Faculty: Unspecified
Divisions: Unspecified
Subjects: no entry
Uncontrolled Keywords:
KeywordsLanguage
RANDOMIZED PHASE-III; BRAIN-STEM TUMORS; HISTONE H3.3; SAFETY; COMPLICATIONS; EFFICACY; RADIOTHERAPY; TEMOZOLOMIDE; METAANALYSIS; MORBIDITYMultiple languages
Clinical Neurology; SurgeryMultiple languages
Refereed: Yes
URI: http://kups.ub.uni-koeln.de/id/eprint/13318

Downloads

Downloads per month over past year

Altmetric

Export

Actions (login required)

View Item View Item